Tianyi Liu

Tianyi Liu has extensive experience in the fields of epidemiology and health technology assessment (HTA). They served as a Senior Real-World Evidence and Health Economics Specialist at AstraZeneca from 2017 to 2018, where they successfully conducted multiple studies and published several research papers. Currently, as an HTA Senior Manager at Roche since 2025, Tianyi focuses on ophthalmology, anti-infectives, and immuno-oncology, developing comprehensive evidence frameworks to support post-market value recognition. They previously held roles at Johnson & Johnson as an Associate Manager and at Roche as an HTA Associate Manager.